VEGFA and cancer: The authors quantitatively demonstrated that compared to targeting either VEGF or FGF in isolation, simultaneous targeting both pathways showed potential synergism, resulted in higher efficacy, and a faster and more sustained response in inhibiting the activation of ERK, informing the development of combination anti‐angiogenic therapies targeting both pathways in cancer treatment (Song & Finley, 2018).